Patient characteristics
| Characteristic . | Number (n = 153) . | % . |
|---|---|---|
| Male/female | 84/69 | 55/45 |
| Median age, y (range) | 31 (14-65) | |
| Number of risk factors* | ||
| 0 | 36 | 24 |
| 1 | 51 | 33 |
| 2 | 56 | 37 |
| 3 | 8 | 5 |
| Bulk (≥ 5 cm) | 46 | 30 |
| Relapsed/refractory | 101/52 | 66/34 |
| Remission ≤ 1 y | 37 | 24 |
| Extranodal disease | 66 | 43 |
| B symptoms | 26 | 17 |
| Previous radiotherapy | 79 | 52 |
| IFRT administered | 115 | 75 |
| ASCT regimen (TLI/chemo) | 66/87 | 43/57 |
| Imaging modality | ||
| Gallium | 110 | 72 |
| PET | 42 | 28 |
| FI response | ||
| Positive | 42 | 27 |
| Negative | 110 | 72 |
| CT response | ||
| Complete response | 44 | 29 |
| Partial response | 60 | 39 |
| Minimal response | 43 | 28 |
| Characteristic . | Number (n = 153) . | % . |
|---|---|---|
| Male/female | 84/69 | 55/45 |
| Median age, y (range) | 31 (14-65) | |
| Number of risk factors* | ||
| 0 | 36 | 24 |
| 1 | 51 | 33 |
| 2 | 56 | 37 |
| 3 | 8 | 5 |
| Bulk (≥ 5 cm) | 46 | 30 |
| Relapsed/refractory | 101/52 | 66/34 |
| Remission ≤ 1 y | 37 | 24 |
| Extranodal disease | 66 | 43 |
| B symptoms | 26 | 17 |
| Previous radiotherapy | 79 | 52 |
| IFRT administered | 115 | 75 |
| ASCT regimen (TLI/chemo) | 66/87 | 43/57 |
| Imaging modality | ||
| Gallium | 110 | 72 |
| PET | 42 | 28 |
| FI response | ||
| Positive | 42 | 27 |
| Negative | 110 | 72 |
| CT response | ||
| Complete response | 44 | 29 |
| Partial response | 60 | 39 |
| Minimal response | 43 | 28 |
Risk factors (determined before ST): B symptoms, extranodal disease, or remission duration ≤ 1 year.